Fibrotic disorders in the eye: targets of gene therapy

Area of Science:

• Ophthalmology
• Pathology
• Cell Biology

Background:

• Fibrotic diseases are characterized by myofibroblasts and excessive extracellular matrix accumulation.
• These conditions lead to tissue contraction and impaired function, affecting various organs.
• Ocular tissues are susceptible to fibrotic disorders, impacting vision.

Purpose of the Study:

• To review the pathogenesis of ocular fibrotic disorders.
• To highlight the roles of myofibroblasts and transforming growth factor beta (TGF-β) in eye fibrosis.
• To explore potential therapeutic strategies targeting fibrotic signaling pathways.

Main Methods:

• Review of literature on ocular fibrotic disease pathogenesis.
• Focus on the role of myofibroblasts and TGF-β signaling.
• Discussion of therapeutic interventions, including gene transfer technologies.

Main Results:

• Myofibroblasts are central to fibrotic reactions in ocular tissues.
• Transforming growth factor beta (TGF-β) is a key cytokine activating fibrotic signaling.
• Signal transduction pathways like Smad and mitogen-activated protein kinases are implicated.

Conclusions:

• Understanding the pathogenesis of ocular fibrotic diseases is crucial for developing effective treatments.
• Modulating TGF-β signaling pathways and related molecules shows promise for preventing or treating these conditions.
• Gene transfer and other technologies offer potential therapeutic avenues for fibrotic eye diseases.